IMB-1001 | m-entrepreneurship.com

Product Name :
IMB-1001

Search keywords :
DNAM1

drugId :
null

Target Vo:
CD226 antigen

Target Vo Short Name :
CD226

Moa_Name:
CD226 antigen blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
TNAX Biopharma Corp

Active Company_Name :
IMIDomics Inc

Active Indication_Name:
Inflammation

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bcl2 Antibody (YA824)
PPAR alpha Antibody
TIMP2 Antibody: TIMP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to TIMP2. It can be used for WB,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts